Variant report

Variant	esv3420235
Chromosome Location	chr3:43326048-43330246
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:43327734-43328196	HepG2	liver:	n/a	n/a
2	ARID3A	chr3:43327766-43327832	K562	blood:	n/a	n/a
3	ARID3A	chr3:43329912-43330794	HepG2	liver:	n/a	n/a
4	ARID3A	chr3:43328109-43328122	K562	blood:	n/a	n/a
5	ATF1	chr3:43327620-43328180	K562	blood:	n/a	n/a
6	ATF1	chr3:43326607-43326757	K562	blood:	n/a	n/a
7	ATF3	chr3:43327879-43328116	K562	blood:	n/a	chr3:43327994-43328009 chr3:43327998-43328008 chr3:43327995-43328008 chr3:43327995-43328005 chr3:43327998-43328005 chr3:43327995-43328006 chr3:43327996-43328007 chr3:43327998-43328006 chr3:43327996-43328007 chr3:43327995-43328008 chr3:43327995-43328005 chr3:43327994-43328007 chr3:43327998-43328008
8	BHLHE40	chr3:43327636-43328158	GM12878	blood:	n/a	chr3:43328124-43328140 chr3:43328135-43328151 chr3:43328051-43328067 chr3:43328127-43328143 chr3:43328126-43328142 chr3:43328052-43328068
9	BHLHE40	chr3:43327317-43327927	HepG2	liver:	n/a	n/a
10	BHLHE40	chr3:43327568-43328118	K562	blood:	n/a	chr3:43328051-43328067 chr3:43328052-43328068
11	BRCA1	chr3:43327625-43328173	Hela-S3	cervix:	n/a	n/a
12	BRCA1	chr3:43327652-43328018	H1-hESC	embryonic stem cell:	n/a	n/a
13	BRCA1	chr3:43328162-43328165	HepG2	liver:	n/a	n/a
14	CBX3	chr3:43327511-43327953	K562	blood:	n/a	n/a
15	CCNT2	chr3:43327739-43328725	K562	blood:	n/a	n/a
16	CEBPB	chr3:43328384-43328614	HepG2	liver:	n/a	n/a
17	CEBPB	chr3:43328472-43328608	K562	blood:	n/a	n/a
18	CEBPB	chr3:43327764-43328102	Hela-S3	cervix:	n/a	n/a
19	CEBPD	chr3:43327798-43328232	HepG2	liver:	n/a	n/a
20	CHD1	chr3:43328042-43328280	GM12878	blood:	n/a	n/a
21	CHD1	chr3:43327287-43327662	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD1	chr3:43328730-43328891	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD2	chr3:43327719-43328208	K562	blood:	n/a	chr3:43327825-43327835
24	CHD2	chr3:43327202-43327285	HepG2	liver:	n/a	n/a
25	CHD2	chr3:43327658-43328189	GM12878	blood:	n/a	chr3:43327825-43327835
26	CHD2	chr3:43328658-43328779	K562	blood:	n/a	n/a
27	CHD2	chr3:43327647-43327901	H1-hESC	embryonic stem cell:	n/a	chr3:43327825-43327835
28	CHD2	chr3:43327720-43328117	HepG2	liver:	n/a	chr3:43327825-43327835
29	CHD2	chr3:43327035-43327071	K562	blood:	n/a	n/a
30	CHD2	chr3:43327330-43328199	Hela-S3	cervix:	n/a	chr3:43327825-43327835
31	CREB1	chr3:43327820-43328186	A549	lung:	n/a	chr3:43327995-43328008
32	CREB1	chr3:43327620-43328342	A549	lung:	n/a	chr3:43327995-43328008
33	CREB1	chr3:43327461-43328353	K562	blood:	n/a	chr3:43327995-43328008
34	CREB1	chr3:43327804-43328145	ECC-1	luminal epithelium:	n/a	chr3:43327995-43328008
35	CREB1	chr3:43327526-43328311	GM12878	blood:	n/a	chr3:43327995-43328008
36	CREB1	chr3:43327641-43328303	K562	blood:	n/a	chr3:43327995-43328008
37	CREB1	chr3:43327639-43328294	H1-hESC	embryonic stem cell:	n/a	chr3:43327995-43328008
38	CREB1	chr3:43327583-43328333	HepG2	liver:	n/a	chr3:43327995-43328008
39	CREB1	chr3:43327816-43328162	ECC-1	luminal epithelium:	n/a	chr3:43327995-43328008
40	CREB1	chr3:43327555-43328312	H1-hESC	embryonic stem cell:	n/a	chr3:43327995-43328008
41	CREB1	chr3:43327614-43328307	HepG2	liver:	n/a	chr3:43327995-43328008
42	CREB1	chr3:43327634-43328339	GM12878	blood:	n/a	chr3:43327995-43328008
43	CTCF	chr3:43327675-43327794	Fibrobl	skin:	n/a	chr3:43327712-43327725
44	CTCF	chr3:43328160-43328310	HCPEpiC	choroid plexus:	n/a	n/a
45	CTCF	chr3:43328180-43328330	GM12865	blood:	n/a	n/a
46	CTCF	chr3:43327700-43327850	HCT-116	colon:	n/a	chr3:43327712-43327725
47	CTCF	chr3:43327679-43327817	GM10248	blood:	n/a	chr3:43327712-43327725
48	CTCF	chr3:43327500-43327650	A549	lung:	n/a	n/a
49	CTCF	chr3:43327657-43327838	GM12878	blood:	n/a	chr3:43327712-43327725
50	CTCF	chr3:43327680-43327830	GM12874	blood:	n/a	chr3:43327712-43327725

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:43327880-43327930	HCM	heart:	n/a
2	chr3:43327880-43327930	HCM	heart:	n/a
3	chr3:43327362-43327412	HepG2	liver:	n/a
4	chr3:43327699-43327749	T-47D	breast:	n/a
5	chr3:43327465-43327515	GM12891	blood:	n/a
6	chr3:43327465-43327515	GM12878	blood:	n/a
7	chr3:43327465-43327515	AG09319	gingival:	n/a
8	chr3:43328001-43328051	ProgFib	skin:	n/a
9	chr3:43328001-43328051	BE2_C	brain:	n/a
10	chr3:43328001-43328051	GM19239	blood:	n/a
11	chr3:43327699-43327749	SK-N-SH	brain:	n/a
12	chr3:43328001-43328051	NB4	blood:	n/a
13	chr3:43327362-43327412	Hela-S3	cervix:	n/a
14	chr3:43327362-43327412	HCF	heart:	n/a
15	chr3:43327880-43327930	IMR90	lung:	fetal
16	chr3:43327362-43327412	U87	brain:	n/a
17	chr3:43327699-43327749	NB4	blood:	n/a
18	chr3:43328001-43328051	IMR90	lung:	fetal
19	chr3:43327699-43327749	AoSMC	blood vessel:	n/a
20	chr3:43327362-43327412	HRE	kidney:	n/a
21	chr3:43327699-43327749	GM12878	blood:	n/a
22	chr3:43327699-43327749	SK-N-SH_RA	brain:	n/a
23	chr3:43327362-43327412	HRPEpiC	eye:	n/a
24	chr3:43327362-43327412	GM12892	blood:	n/a
25	chr3:43327699-43327749	ovcar-3	ovarian:	n/a
26	chr3:43328001-43328051	RPTEC	kidney:	n/a
27	chr3:43327699-43327749	HCM	heart:	n/a
28	chr3:43327465-43327515	PrEC	prostate:	n/a
29	chr3:43328001-43328051	BJ	skin:	n/a
30	chr3:43328001-43328051	Caco-2	colon:	n/a
31	chr3:43328001-43328051	NH-A	brain:	n/a
32	chr3:43327362-43327412	RPTEC	kidney:	n/a
33	chr3:43327699-43327749	HPAEpiC	pulmonary alveolar:	n/a
34	chr3:43327880-43327930	HEK293	kidney:	embryo
35	chr3:43327362-43327412	NT2-D1	testis:	n/a
36	chr3:43328001-43328051	Jurkat	blood:	n/a
37	chr3:43327362-43327412	HPAEpiC	pulmonary alveolar:	n/a
38	chr3:43328001-43328051	PFSK-1	brain:	n/a
39	chr3:43327880-43327930	GM12892	blood:	n/a
40	chr3:43328001-43328051	AG10803	skin:	n/a
41	chr3:43327880-43327930	Jurkat	blood:	n/a
42	chr3:43327465-43327515	CMK	blood:	n/a
43	chr3:43327699-43327749	HCT-116	colon:	n/a
44	chr3:43327699-43327749	PANC-1	pancreas:	n/a
45	chr3:43327465-43327515	HCPEpiC	choroid plexus:	n/a
46	chr3:43327880-43327930	AG04450	lung:	fetal
47	chr3:43327880-43327930	GM12891	blood:	n/a
48	chr3:43327699-43327749	RPTEC	kidney:	n/a
49	chr3:43327362-43327412	PrEC	prostate:	n/a
50	chr3:43327362-43327412	HIPEpiC	eye:	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:43328082..43330424-chr3:43353703..43355564,2	K562	blood:
2	chr3:43327921..43329533-chr3:43329941..43331733,2	MCF-7	breast:
3	chr3:43327783..43328333-chr5:32173796..32174464,2	Hela-S3	cervix:
4	chr10:98346013..98346591-chr3:43327414..43328126,2	Hela-S3	cervix:
5	chr3:43314193..43316141-chr3:43325214..43327876,2	K562	blood:
6	chr3:43325116..43327718-chr3:43329418..43331490,2	K562	blood:
7	chr3:43329569..43331859-chr3:43336954..43339880,3	MCF-7	breast:
8	chr20:30192245..30193126-chr3:43327692..43328283,2	Hela-S3	cervix:
9	chr3:43328576..43330209-chr3:43363736..43365348,2	K562	blood:
10	chr3:43328259..43329793-chr3:43345734..43348023,2	K562	blood:
11	chr19:1249504..1250049-chr3:43327521..43328330,2	Hela-S3	cervix:
12	chr3:43328459..43331117-chr3:43356191..43358697,2	K562	blood:
13	chr14:103988769..103989622-chr3:43327887..43328473,2	HCT-116	colon:
14	chr2:208394589..208395128-chr3:43327696..43328487,2	Hela-S3	cervix:
15	chr3:43327640..43330625-chr3:43731199..43733951,3	K562	blood:
16	chr3:43320796..43322949-chr3:43328990..43330664,2	K562	blood:
17	chr3:43305979..43308043-chr3:43325669..43327950,2	MCF-7	breast:
18	chr3:43325116..43327718-chr3:43329418..43331490,2	K562	blood:

Variant related genes	Relation type
SNRK	TF binding region
SNRK	CpG island
ENSG00000118260	chromatin interactions
ENSG00000011198	chromatin interactions
ENSG00000163788	chromatin interactions
ENSG00000241939	chromatin interactions
ENSG00000160746	chromatin interactions
ENSG00000167470	chromatin interactions
ENSG00000166165	chromatin interactions
ENSG00000125968	chromatin interactions
ENSG00000113384	chromatin interactions
ENSG00000077147	chromatin interactions

Extended variants
information (count: 112 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:112 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs370078187	chr3:43326141-43326142	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs538527947	chr3:43326158-43326159	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs548472833	chr3:43326203-43326204	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs575087961	chr3:43326292-43326293	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs73075024	chr3:43326315-43326316	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs372040201	chr3:43326410-43326411	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs5023544	chr3:43326421-43326422	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs146632602	chr3:43326427-43326428	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs146725363	chr3:43326436-43326437	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs574572420	chr3:43326464-43326465	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs186239761	chr3:43326490-43326491	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs559673109	chr3:43326642-43326643	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs528805598	chr3:43326651-43326652	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs188997047	chr3:43326714-43326715	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs373649482	chr3:43326720-43326721	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs373474300	chr3:43326742-43326743	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs542007687	chr3:43326786-43326787	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs55808588	chr3:43326795-43326796	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs561885592	chr3:43326840-43326841	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs35415328	chr3:43326850-43326851	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs11709517	chr3:43326887-43326888	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs77507993	chr3:43326912-43326913	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs570905111	chr3:43326962-43326963	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs546795330	chr3:43326989-43326990	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs566512042	chr3:43327016-43327017	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs531510168	chr3:43327025-43327026	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs140833539	chr3:43327106-43327107	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs199539199	chr3:43327214-43327215	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs558522896	chr3:43327216-43327217	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs143014140	chr3:43327228-43327229	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs537878085	chr3:43327288-43327289	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs73831233	chr3:43327291-43327292	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs574615932	chr3:43327338-43327339	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs73831234	chr3:43327343-43327344	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs559914489	chr3:43327358-43327359	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs374755897	chr3:43327375-43327376	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs538317724	chr3:43327437-43327438	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs545687845	chr3:43327439-43327440	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs565486878	chr3:43327503-43327504	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs531100786	chr3:43327610-43327611	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs575422236	chr3:43327652-43327653	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs538439055	chr3:43327688-43327689	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs145900249	chr3:43327714-43327715	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
44	rs560918933	chr3:43327725-43327726	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
45	rs187439730	chr3:43327773-43327774	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
46	rs530147883	chr3:43327821-43327822	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
47	rs368350776	chr3:43327853-43327854	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
48	rs546737141	chr3:43327907-43327908	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
49	rs566660290	chr3:43327909-43327910	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
50	rs532252766	chr3:43327918-43327919	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	18923191	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Wilms tumour	17204608	CNVD
Biliary cancer	19435499	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-small cell lung cancer	21829676	CNVD
Kartagener syndrome	16639409	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Breast cancer	21509527	CNVD
Melanoma	21693616	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Breast cancer	20409316	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:500 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:43318800-43327800	Weak transcription	Small Intestine	intestine
2	chr3:43321600-43327000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr3:43324000-43327200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr3:43325200-43326600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
5	chr3:43325200-43327400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr3:43325400-43326400	Weak transcription	HUVEC	blood vessel
7	chr3:43325800-43326200	Enhancers	NHEK	skin
8	chr3:43326200-43327200	Weak transcription	NHEK	skin
9	chr3:43326200-43327400	Enhancers	Fetal Brain Male	brain
10	chr3:43326400-43327400	Enhancers	Adipose Nuclei	Adipose
11	chr3:43326400-43327600	Enhancers	HUVEC	blood vessel
12	chr3:43326600-43326800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
13	chr3:43326600-43327000	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr3:43326600-43327000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
15	chr3:43326600-43327000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
16	chr3:43326600-43327000	Bivalent Enhancer	HepG2	liver
17	chr3:43326600-43327200	Enhancers	H1 Cell Line	embryonic stem cell
18	chr3:43326600-43327200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr3:43326600-43327200	Enhancers	Fetal Brain Female	brain
20	chr3:43326600-43327400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
21	chr3:43326600-43327400	Enhancers	Thymus	Thymus
22	chr3:43326800-43327400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
23	chr3:43326800-43327600	Enhancers	Fetal Thymus	thymus
24	chr3:43326800-43327600	Enhancers	Spleen	Spleen
25	chr3:43327000-43327200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
26	chr3:43327000-43327200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
27	chr3:43327000-43327200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
28	chr3:43327000-43327200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
29	chr3:43327000-43327200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
30	chr3:43327000-43327200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr3:43327000-43327200	Enhancers	Primary neutrophils fromperipheralblood	blood
32	chr3:43327000-43327200	Enhancers	Primary T helper cells PMA-I stimulated	--
33	chr3:43327000-43327200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
34	chr3:43327000-43327200	Enhancers	Lung	lung
35	chr3:43327000-43327200	Enhancers	Dnd41	blood
36	chr3:43327000-43327200	Enhancers	Hela-S3	cervix
37	chr3:43327000-43327400	Enhancers	Fetal Stomach	stomach
38	chr3:43327000-43327400	Enhancers	Psoas Muscle	Psoas
39	chr3:43327000-43327400	Enhancers	Stomach Smooth Muscle	stomach
40	chr3:43327000-43327400	Flanking Bivalent TSS/Enh	HepG2	liver
41	chr3:43327000-43327600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
42	chr3:43327000-43327600	Enhancers	Esophagus	oesophagus
43	chr3:43327000-43327600	Enhancers	Fetal Muscle Leg	muscle
44	chr3:43327000-43327600	Enhancers	Left Ventricle	heart
45	chr3:43327000-43327600	Enhancers	Right Ventricle	heart
46	chr3:43327000-43327600	Enhancers	Skeletal Muscle Male	skeletal muscle
47	chr3:43327000-43327600	Enhancers	Stomach Mucosa	stomach
48	chr3:43327200-43327400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
49	chr3:43327200-43327400	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr3:43327200-43327400	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links